Galera Therapeutics, Inc. (GRTX)
| Market Cap | 3.56B+328.8% |
| Revenue (ttm) | 0 |
| Net Income | 149.03M+1021.8% |
| EPS | 303.74+616.9% |
| Shares Out | 1.04M |
| PE Ratio | 0.06 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 420 |
| Open | 16.00 |
| Previous Close | 15.62 |
| Day's Range | 16.00 - 17.15 |
| 52-Week Range | 0.09 - 30.00 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | n/a |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$GRTX stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in GRTX holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by GRTX's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
GRTX Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New GRTX patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to GRTX from public contracts
Source: USAspending.gov
GRTX Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from GRTX’s recent data — informational, not investment advice